STAYING on the edge of the latest developments in coronary stents, the National Heart Institute (IJN) is currently involved in the clinical trials of two new coronary stents.
Produced by two different pharmaceutical companies, these fourth-generation stents each take a different approach to solving the problems faced by previous generations of coronary stents.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!